tm logo
KINDEVA
Live/Pending
FOURTH EXTENSION - GRANTED

granted

on 13 Sep 2024

Last Applicant/ Owned by

11200 Hudson Road

Woodbury

MN

55129

Serial Number

97004708 filed on 31st Aug 2021

Registration Number

N/A

Correspondent Address

Christine Feller

Christine Feller ArentFox Schiff LLP

Washington, DC 20006

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

KINDEVA

Inhalers for therapeutic and medical uses; chambers for inhalers; spacers for inhalers; medical apparatus for facilitating the inhalation of pharmaceutical preparations, namely, dose counters, dose indicators for medical purposes, and metal canisters being a component of inhalers; instruments and apparatus provided empty for the inhalation of pharmaceutical and biological preparations; drug delive Read More

Classification Information


Class [010]
Medical Instrument Products


Inhalers for therapeutic and medical uses; chambers for inhalers; spacers for inhalers; medical apparatus for facilitating the inhalation of pharmaceutical preparations, namely, dose counters, dose indicators for medical purposes, and metal canisters being a component of inhalers; instruments and apparatus provided empty for the inhalation of pharmaceutical and biological preparations; drug delivery systems composed of microneedles in the nature of needle-shaped microstructures, sold empty, for use in delivery of pharmaceutical and biological preparations


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [006]
Metal Products


Metal canisters, sold empty, for use in conjunction with inhalers


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Drug delivery agents in the form of transdermal patches, creams, gels, lotions, ointments, capsules, liquids, tablets, and oral transmucosals that facilitate the delivery of pharmaceutical and biological preparations; transdermal drug delivery patches for use in pain management; transdermal drug delivery patches for use in the treatment of osteoporosis, cardiac disorders, coronary artery disease, diabetes, menopausal symptoms, and central nervous system disorders; drug delivery devices, sold filled, for the subcutaneous and intradermal administration of pharmaceutical and biological preparations for the treatment of a wide variety of conditions and that are developed by or in collaboration with the distributors of the filled devices; inhalers sold filled with aerosol inhalation products for the treatment of a wide variety of conditions and that are developed by or in collaboration with the distributors of the filled devices; pharmaceutical and biological preparations for inhalation for use in treatment of respiratory diseases and disorders; pharmaceutical and biological preparations for inhalation for use in treatment of cancer; pharmaceutical and biological preparations for use in the treatment of diabetes, osteoporosis, autoimmune disorders, and cancer; pharmaceutical and biological preparations for use with vaccinations; drug delivery systems composed of microneedles in the nature of needle-shaped microstructures sold with pharmaceutical and biological preparations filling or coating the microneedles intended for the treatment of a wide variety of conditions and that are developed by or in collaboration with the distributors of the filled devices


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 97004708

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 452735.00210

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
17th Sep 2024REVIEW OF CORRESPONDENCE COMPLETE
13th Sep 2024SOU EXTENSION 4 GRANTED
13th Sep 2024SOU EXTENSION 4 FILED
13th Sep 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
13th Sep 2024SOU TEAS EXTENSION RECEIVED
18th Apr 2024CORRECTED NOA E-MAILED
18th Apr 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
17th Apr 2024SOU EXTENSION 3 GRANTED
17th Apr 2024DIVISIONAL PROCESSING COMPLETE
02th Apr 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL